-
Mashup Score: 0The Next Wave After Immunotherapy in Cancer Drug Development - 6 hour(s) ago
This Viewpoint discusses the history of immunotherapy and the future of targeted therapy to treat cancer.
Source: jamanetwork.comCategories: General Medicine NewsTweet
-
Mashup Score: 0Breast Cancer Outcomes in Transgender and Gender-Diverse Patients in the National Cancer Database - 7 hour(s) ago
This cohort study examines breast cancer outcomes in transgender and gender-diverse patients compared with cisgender patients, including overall survival and sociodemographic characteristics.
Source: jamanetwork.comCategories: General Medicine NewsTweet
-
Mashup Score: 0PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non–Small Cell Lung Cancer - 12 hour(s) ago
This cohort study evaluates the efficacy of neoadjuvant programmed cell death 1 protein (PD-1) or programmed cell death 1 ligand 1 (PD-L1) blockade combined with chemotherapy in enhancing surgical outcomes and pathological responses in patients with stage III non–small cell lung cancer.
Source: jamanetwork.comCategories: General Medicine NewsTweet
-
Mashup Score: 0Tomosynthesis vs Digital Mammography Screening in Women with a Family History of Breast Cancer - 1 day(s) ago
This cohort study compares the performance of digital breast tomosynthesis to conventional digital mammography in screening women with a family history of breast cancer.
Source: jamanetwork.comCategories: General Medicine NewsTweet
-
Mashup Score: 101PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non–Small Cell Lung Cancer - 2 day(s) ago
This cohort study evaluates the efficacy of neoadjuvant programmed cell death 1 protein (PD-1) or programmed cell death 1 ligand 1 (PD-L1) blockade combined with chemotherapy in enhancing surgical outcomes and pathological responses in patients with stage III non–small cell lung cancer.
Source: jamanetwork.comCategories: General Medicine NewsTweet
-
Mashup Score: 38Neoadjuvant Nivolumab Plus Chemotherapy and Chemoradiation Therapy in HPV-Negative Head and Neck Cancer - 3 day(s) ago
This phase 2 nonrandomized clinical trial evaluates the deep response rate and tolerability of neoadjuvant nivolumab plus chemotherapy followed by response-stratified chemoradiation therapy in nonvirally mediated stage IVa/b head and neck squamous cell carcinoma.
Source: jamanetwork.comCategories: General Medicine NewsTweet
-
Mashup Score: 26Neoadjuvant Nivolumab Plus Chemotherapy and Chemoradiation Therapy in HPV-Negative Head and Neck Cancer - 4 day(s) ago
This phase 2 nonrandomized clinical trial evaluates the deep response rate and tolerability of neoadjuvant nivolumab plus chemotherapy followed by response-stratified chemoradiation therapy in nonvirally mediated stage IVa/b head and neck squamous cell carcinoma.
Source: jamanetwork.comCategories: General Medicine NewsTweet
-
Mashup Score: 70Adjuvant Chemoradiotherapy vs Radiotherapy for Patients With Intermediate-Risk Cervical Cancer - 5 day(s) ago
This cohort study examines the association between adjuvant chemoradiotherapy and overall survival compared with radiotherapy alone in patients with intermediate-risk cervical cancer.
Source: jamanetwork.comCategories: General Medicine NewsTweet
-
Mashup Score: 32
This cohort study examines the harms and benefits of regimens containing immune checkpoint inhibitors in individuals with non–small cell lung cancer.
Source: jamanetwork.comCategories: General Medicine NewsTweet
-
Mashup Score: 38Persistent Prostate-Specific Antigen Following Radical Prostatectomy for Prostate Cancer and Mortality Risk - 6 day(s) ago
This cohort study evaluates the time necessary to accurately document a persistent prostate-specific antigen level after radical prostatectomy.
Source: jamanetwork.comCategories: General Medicine NewsTweet
Viewpoint discusses how oncology drug development is shifting from immunotherapy to targeted therapies like antibody-drug conjugates and radioligand therapy. https://t.co/qp8IRdNV6S https://t.co/hJPIeElnuK